NOS1, nitric oxide synthase 1, 4842

N. diseases: 521; N. variants: 38
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.040 Biomarker group BEFREE BD-II and BD-NOS more frequently had an AD at psychiatric onset, with panic disorder being the most common AD. 31733039 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.040 GeneticVariation group BEFREE Contrary, diazepam treated animals under Control protocol expressed anxiety and evidenced an increased hippocampal-plasticity, without alterations in NOS-1 expression. 31299121 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.040 Biomarker group BEFREE Thereby, one candidate pathway is neuronal nitric oxide (NO) signaling, and accordingly, rodent studies have identified NO synthase (NOS-I), encoded by NOS1, as a strong molecular candidate for modulating anxiety and hippocampus-dependent learning processes. 26746182 2016
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.040 Biomarker group BEFREE Taken together, NOS1 knockdown mice display a characteristic behavioural profile consisting of reduced anxiety and impaired learning and memory, paralleled by differential expression of the glucocorticoid receptor and GABAergic genes. 17982880 2007